Baylor Breast Care Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor Breast Care Center sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Baylor Breast Care Center: 15 sponsored US clinical trials, 1 recruiting.
Baylor Breast Care Center sponsors 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 3 trials.
Top-decile sponsor footprint
Baylor Breast Care Center ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
5 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (41.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
15 total, page 1 of 1
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT05020860
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
NCT03324425
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
NCT00999804
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
NCT00905021
Brain Mets - Capecitabine Plus Sunitinib and WBRT
NCT00570908
Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients
NCT00817531
Lapatinib and Trastuzumab With or Without Endocrine Therapy
NCT00548184
Nexium Study To Suppress Nausea During Chemotherapy
NCT00206440
Neoadjuvant GW572016 to Treat Breast Cancer
NCT00206427
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
NCT00206492
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
NCT00206414
Biologic Correlative Taxotere/AC
NCT00206466
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer
NCT00206453
Bexarotene in Preventing Breast Cancer in Women at Genetic Risk
NCT00055991
Neoadjuvant Taxotere
NCT00206505
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 12 |
| Phase 3 | 1 |
What is open in the Baylor Breast Care Center pipeline
1 recruiting of 15 indexed (7% open); 5 completed (33%).
Phase mix: 1 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor Breast Care Center: open-pipeline peers nationwide
Peers matched on 15 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Baylor Breast Care Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 trials (± recruiting share)
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Geron Corporation · 7% recruiting · 15 trials
- Guerbet · 7% recruiting · 15 trials
- Joanne Kurtzberg, MD · 7% recruiting · 15 trials
- Lakefront Biotherapeutics · 7% recruiting · 15 trials
Related
What to do with this Baylor Breast Care Center page
15 registered trials is a research-attention snapshot, not an endorsement of Baylor Breast Care Center or any single study.
- 1 of Baylor Breast Care Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Baylor Breast Care Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Baylor Breast Care Center pipeline card: 15 registered trials from official public datasets.Report a data error.